Task force sees no need yet for additional FDA nanotech regulation

07/25/2007 | Washington Post, The

A federal task force concludes there is no urgent need at present for the FDA to develop additional regulatory authority for nanotechnology-based products, such as drugs. The report said such products may not even need to be labeled to alert consumers but said the agency should increase its knowledge of the science.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC